发明名称 FORMULATION FOR ORAL ADMINISTRATION OF PROTEINS
摘要 PROBLEM TO BE SOLVED: To provide pharmaceutical formulations of orally administered proteins which can be stabilized from oxidative degradation and inactivation in the stomach and gastrointestinal (GI) tract.SOLUTION: The invention provides a solid pharmaceutical formulation of a barley endoprotease B-2 suitable for oral administration with a unit dosage form, or a recombinant form or modified form of barley endoprotease B-2. The solid pharmaceutical formulation is a capsule form; a powder, sprinkle, or particle in the capsule or a sachet; or a tablet form, comprising about 2 to 50 mg of sodium metabisulfite and 50-2000 mg of the EPB2.
申请公布号 JP2015110610(A) 申请公布日期 2015.06.18
申请号 JP20150005678 申请日期 2015.01.15
申请人 ALVINE PHARMACEUTICALS INC 发明人 MATTHEW JOHN SIEGEL;BRET BERNER
分类号 A61K38/46;A61K9/14;A61K9/20;A61K9/48;A61K47/02;A61K47/12;A61K47/18;A61P1/00;A61P1/04;A61P17/00 主分类号 A61K38/46
代理机构 代理人
主权项
地址